Alaunos Therapeutics | ZIOP - Выручка от реализации





Продажи Изменить Дата
Alaunos Therapeutics USD 2K 2K 2025-03
Amgen USD 8.62B 1.28B 2026-03
AstraZeneca USD 15.29B 213M 2026-03
Baxter International USD 2.7B 270M 2026-03
Biogen USD 2.25B 30M 2026-03
Bioline Rx USD 427K 123K 2025-09
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Celltrion KRW 1.15T 180B 2026-03
Corcept Therapeutics USD 164.9M 37.22M 2026-03
Cspc Pharmaceutical CNY 6.47B 355.1M 2026-03
Curis USD 1.14M 1.41M 2025-12
Deva Holding AS TRY 2.32B 418.58M 2023-09
Dianthus Therapeutics USD 284K 112K 2025-12
Divis Laboratories Ltd INR 28.31B 2.27B 2026-03
Gilead Sciences USD 7B 930M 2026-03
GlaxoSmithKline GBP 7.63B 991M 2026-03
Incyte USD 1.27B 240M 2026-03
Intrexon USD 717K 511K 2024-06
Ionis Pharmaceuticals USD 246M 43M 2026-03
J&J USD 24.1B 500M 2026-03
Kangmei Pharma CNY 1.37B 101.16M 2025-09
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Laboratorios Farma EUR 448.66M 67.82M 2023-12
Medical Developments International AUD 21.57M 12.04M 2025-12
Merck USD 16.29B 110M 2026-03
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Novartis USD 13.11B 226M 2026-03
Organigram Holdings CAD 63.54M 16.52M 2025-12
Pfizer USD 14.5B 3.08B 2026-03
Pharma Mar EUR 42.9M 47.3M 2026-03
PTC Therapeutics USD 273M 108.3M 2026-03
Qiagen NV USD 419.22M 38.16M 2026-03
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sangamo BioSciences USD 356K 125K 2024-06
Sartorius EUR 899.1M 28.5M 2026-03
Sino Biopharmaceutical CNY 14.26B 3.31B 2025-12
TG Therapeutics USD 194.8M 2.23M 2026-03
Tilray USD 217.51M 74.75M 2025-12
Verastem USD 17.54M 7.53M 2025-12
Zealand Pharma A/S 68.91M 19.35M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 2.72B 837.63M 2026-03